by dex.manley | Nov 15, 2023 | News
Lifestyle factors play a major role in the development of oral cancer. Among the many clinical risk factors, smoking and alcohol top the list of behaviors that most directly increase a patient’s risk of oral cancer. Alone, smoking increases oral cancer risk by ten...
by dex.manley | Nov 9, 2023 | News
Lakeway, Texas (Date: 11-9-2023) – Vigilant Biosciences®, Inc. (“Vigilant”), an innovator and creator of solutions aimed at facilitating the early detection of oral cancer, is proud to announce the launch of its transformative product, the BeVigilant™...
by dex.manley | Oct 10, 2023 | News
As a pioneer in early oral cancer detection solutions, Vigilant Biosciences® strives to help clinicians diagnose oral cancer in Stages I and II to accelerate treatment initiation and improve patient outcomes. Our team leverages decades of specialized clinical...
by dex.manley | Oct 4, 2023 | News
Vigilant Biosciences® Leads the Charge Against Oral Cancer Lakeway, Texas (Oct. 4, 2023) – Vigilant Biosciences®, Inc. (“Vigilant”), an industry-leading developer of cutting-edge solutions that accelerate the detection of oral cancer, announces the release of its...
by dex.manley | Sep 19, 2023 | News
Dusseldorf, Germany (Sept. 19, 2023) – Vigilant Biosciences®, Inc. (“Vigilant”), a leading innovator and developer of solutions that assist in the early detection of oral cancer, announces the release of its breakthrough product, the BeVigilant™ OraFusion™ System, in...
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES